These days you have to be very careful who you believe when it comes to “miracle” treatments because the market is full of scams.
Fighting aging and disease with scamming “treatments”
The Food and Drug Administration has issued a forceful warning today saying that transfusions of young donor plasma which have been marketed as fighting aging and disease are more than unproven – they seem also to be dangerous and harmful.
More and more people have been hearing about Young Blood Miracle Treatments in which medical startups are charging a ton of cash to inject older patients with infusions of blood plasma coming from young donors.
The latest reports coming from Huffington Post say that “If the reported claims about those treatments sound too good to be true, that’s because they are, according to the FDA.”
They continue and write that “Injecting young donor plasma to treat or prevent aging, as well as conditions such as Alzheimer’s and Parkinson’s disease, has “no proven clinical benefits” like those advertised and is “potentially harmful,” FDA Commissioner Scott Gottlieb said in a statement. Peter Marks, director of the agency’s Center for Biologics Evaluation and Research, joined him in issuing the warning. “
More preyed patients
They continued and quoted the experts saying “Simply put, we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies,” Gottlieb and Marks said.
Another thing that’s not good at all is the fact that such promotion of young plasma for these unproven purposes will also discourage patients who are suffering from a serious disease from receiving effective and truly safe treatments.
The FDA will be considering taking regulatory and enforcement actions against companies that are abusing the patients’ trust and put their health in danger by promoting all these fake treatments that have never been proven to be effective.
We recommend that you check out Huffington Post’s investigation into Ambrosia, “a startup that sells young plasma treatments that offer numerous alleged potential benefits.”
Rada attended the courses in the Faculty of Letters, Romanian-English section, and finished the Faculty of Theatre and Television, Theatrical Journalism section, both within the framework of Babeş-Bolyai University of Cluj-Napoca. Up ’til now, she reviewed books, movies, and theatre-plays, enjoying subjects from the cultural niche. Her experience in writing also intersects the IT niche, given the fact that she worked as a content editor for firms that produce software for mobile devices. She is collaborating with online advertising agencies, writing articles for several websites and blogs.